Fig. 3From: A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancerReporter operator characteristic (ROC) for combinations of proteins in the discovery step. a Benign tumors versus Ovarian cancer stage I–II. b Benign tumors versus Ovarian cancer stage III–IV. c Benign tumors versus Ovarian cancer stage I–IV. d Population controls versus Ovarian cancer stage I–II. e Population controls versus Ovarian cancer stage III–IV. f Population controls versus Ovarian cancer stage I–IV. g Benign tumors versus Endometrial cancer. h Controls versus Endometrial cancer. i Ovarian cancer stage I-IV versus endometrial cancer versusBack to article page